ETFIQData as of Nov 18, 2026. · etfiq.com/funds/rzg

RZG Fact Sheet: Invesco S&P SmallCap 600 Pure Growth ETF

Share
$60.33
close, Nov 18, 2026

Over the year to Nov 18, 2026, RZG returned +17.2% in total and charged 0.35% a year.

1-year total return
+17.2%
to Nov 18, 2026
Expense ratio
0.35%
a year
Net assets
$113m
on Nov 17, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

RZG $11,724 +17.2% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−2.2%
3 months−12.6%
Year to date+11.5%
1 year+17.2%
3 years+49.6%
5 years+10.6%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Progyny Inc1.99%
Acadian Asset Management Inc1.97%
Protagonist Therapeutics Inc1.89%
Arcutis Biotherapeutics Inc1.87%
Clear Secure Inc1.77%
Chefs' Warehouse Inc1.73%
TG Therapeutics Inc1.62%
ACM Research Inc1.54%
Dave Inc1.53%
Sezzle Inc1.49%

RZG top ten by weight, 17.4% of the fund, of its 128 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P SmallCap 600 Pure Growth Index · First traded Mar 7, 2006 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, RZG Fact Sheet: Invesco S&P SmallCap 600 Pure Growth ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/rzg/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/rzg.